ImmunityBio (IBRX) Current Deferred Revenue (2014 - 2018)
ImmunityBio's (IBRX) quarterly Current Deferred Revenue came in at $598000.0 in Q4 2018, up 15.0% year-on-year from $520000.0 in Q4 2017, and up 3.64% on a QoQ basis from $577000.0 in Q3 2018.
ImmunityBio (IBRX) Current Deferred Revenue (2014 - 2018) Analysis & Trends
ImmunityBio (IBRX) has 5 years of Current Deferred Revenue data on file, last reported at $598000.0 in Q4 2018.
- On a quarterly basis, Current Deferred Revenue rose 15.0% year-over-year to $598000.0 in Q4 2018; TTM through Dec 2018 was $598000.0, a 15.0% increase from a year earlier, with the FY2018 full-year figure at $598000.0, up 15.0% from the prior year.
- Current Deferred Revenue for Q4 2018 stood at $598000.0, up from $577000.0 in the prior quarter.
- Over the last five years, Current Deferred Revenue for IBRX reached as high as $598000.0 in Q4 2018 and fell as low as $5000.0 in Q4 2015.
- Historically, Current Deferred Revenue has averaged $407538.5 across 5 years, with a median of $501000.0 in 2017.
- Across the five-year window, Current Deferred Revenue slumped 99.04% in 2015 and surged 3840.0% in 2016, its largest moves.
- Year by year, Current Deferred Revenue stood at $521000.0 in 2014, then slumped by 99.04% to $5000.0 in 2015, then jumped by 3840.0% to $197000.0 in 2016, then jumped by 163.96% to $520000.0 in 2017, then rose by 15.0% to $598000.0 in 2018.
- Per Business Quant data, the three most recent Current Deferred Revenue figures were $598000.0 in Q4 2018, $577000.0 in Q3 2018, and $558000.0 in Q2 2018.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | ImmunityBio | 7.60 Bn | 7.22 Bn | 43.97 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2018 | 598,000.00 |
| Sep 30, 2018 | 577,000.00 |
| Jun 30, 2018 | 558,000.00 |
| Mar 31, 2018 | 539,000.00 |
| Dec 31, 2017 | 520,000.00 |
| Sep 30, 2017 | 501,000.00 |
| Jun 30, 2017 | 484,000.00 |
| Mar 31, 2017 | 215,000.00 |
| Dec 31, 2016 | 197,000.00 |
| Dec 31, 2015 | 5,000.00 |
| Sep 30, 2015 | 342,000.00 |
| Jun 30, 2015 | 241,000.00 |
| Dec 31, 2014 | 521,000.00 |